Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 9, 2015-05 ,pp. : 857-871

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the mineralocorticoid receptor in cardiovascular disease

By Young Morag J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 321-331

Informa Healthcare

Access to resources Recommend Favorite

Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) against Oxidative Stress in Cardiovascular Related Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1465-1470

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage

By  

Current Pharmaceutical Design, Vol. 23, Iss. 15, 2017-06 ,pp. : 2226-2237

Bentham Science Publishers

Access to resources Recommend Favorite

GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting

By  

Current Molecular Pharmacology, Vol. 5, Iss. 3, 2012-11 ,pp. : 317-326

Bentham Science Publishers

Access to resources Recommend Favorite